Tolfenamic acid
As of the edition of 20 October 2026, Tolfenamic acid is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Clotam
- Approvals on record
- 5 in 5 regions
- Holder of the most recent approval
- Sandoz; 2 holders in all
- Registered trials
- 1, 1 stopped early
- Disease areas
- Cancer; Digestive system; Hormones
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 1 | 0 | 0 | 1 |
| All trials | 1 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Orlando Health | Lead sponsor of trials | 2014 to now |